CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 01:39 (871 d 20:27 ago) – Posting: # 18895
Views: 4,064

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

Activity
 Admin contact
21,180 posts in 4,415 threads, 1,476 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time: Saturday 22:06 UTC (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5